Delivery Order SPE2DB22D9367-SPE2DB24FSU85
Award Date
10/31/23
Potential Completion Date
11/22/23
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,614.78 fixed-price contract is for the delivery of 3,750 units of the drug Asparlas (5 mL vials) with a performance period through May 13, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,614.78, is for the delivery of 3,750 units of the drug ASPARLAS (5 mL vials) with a completion date of May 17, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $78,899.37 contract is for the delivery of 3,750 units of the drug Asparlas (5 ml vial) with a completion date of November 30, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $52,599.60, is for the delivery of 3,750 units of the pharmaceutical product Asparlas (5 ml vial) by September 14, 2023. DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $26,299.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the 5 ML vial of the pharmaceutical drug Asparlas. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of 3,750 units of the drug ASPARLAS (5 ML vial) with a ceiling value of $82,844.34. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $110,459.16 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 3,750 units of the 5 ML ASPARLAS (asparaginase erwinia chrysanthemi) vial to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $138,073.90, is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS in 5 ML vials. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $27,614.78 contract is to provide 3,750 units of the pharmaceutical product ASPARLAS (5 mL vials) with an ultimate completion date of April 10, 2024. DMS Pharmaceutical Group holds a $4,999,999 indefinite delivery vehicle (IDV) contract with DLA under the SPE2DB program to supply a broad range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order, valued at $27,614.78, is for the delivery of 3,750 units of the drug Asparlas in 5 mL vials. The order is a firm fixed-price contract with a completion date of May 23, 2024. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA....